Top

Latest share tips: Mony Group, Bellway & more


Updated on 21 February 2025 | 0 Comments

Here's your roundup of the latest share tips. See which companies the experts are buying, selling or holding this week.

Mony Group, Bellway and Gleeson are among the companies under the spotlight this week.

Ready to invest but want to shield your returns from the taxman? Open a Stocks & Shares ISA with Hargreaves Lansdown now.

1. Mony Group – ADD

Symbol: MONY.L

Index: FTSE 100

Money Group share price (Image: Google)

The tech-led savings platform, which trades as MoneySupermarket, revealed that revenue grew 2% to £439 million for the full year 2024.

Jessica Pok, an analyst at Peel Hunt, has maintained her ‘buy’ rating on the stock and has a target price of 280p.

“In the medium term, further progress has the potential to reduce reliance on marketing and increase margins,” she said.

2. Ashmore – BUY

Symbol: ASHM.L

Index: FTSE 250

Ashmore share price (Image: Google)

The specialist emerging markets manager has maintained an interim dividend per share of 4.8p due to its strong financial position, cash generation and near term outlook.

Rae Maile, an analyst at Panmure Liberum, expects some further outflows this year before a gradual recovery.

“History shows that when flows turn, they turn quickly and materially,” he said. “It is likely to be the same this time too.”

Ready to invest but want to shield your returns from the taxman? Open a Stocks & Shares ISA with Hargreaves Lansdown now

3. Bellway – ADD

Symbol: BWY.L

Index: FTSE 250

Bellway share price (Image: Google)

The housebuilder saw volumes increase around 12% in the first half of the year, with selling prices broadly flat.

After a subdued autumn, the spring selling season is showing a pick-up and the order book is 30% ahead of last year, according to Sam Cullen, an analyst at Peel Hunt.

“Bellway is seeing an encouraging improvement in levels of demand, though consumers remain sensitive to mortgage rates,” he said.

4. Optima Health – BUY

Symbol: OPT.L

Index: FTSE AIM 100 Index

Optima share price (Image: Google)

The occupational health company has signed its first license contract for DART – its Digital Assessment Routing Tool.

The agreement with Mersey and West Lancashire Teaching Hospitals NHS Trust follows a four-month pilot study, according to Julie Simmonds, research analyst at Panmure Liberum.

“We see DART as having the potential for significant upside, and a wider rollout remains as upside to our estimates,” she said.

5. Gleeson – BUY

Symbol: GLE.L

Index: FTSE All-Share

Gleeson share price (Image: Google)

The housebuilder delivered a 4% increase in first-half revenue of £158 million and has enjoyed a solid start to the second period.

The reservation rate is 45% ahead of the previous year – helped by the market and the company’s own actions, according to Sam Cullen, an analyst at Peel Hunt.

“Gleeson is operating in an attractive segment of the market, and we expect it to maintain a good sales rate through the balance of the year,” he said.

Ready to invest but want to shield your returns from the taxman? Open a Stocks & Shares ISA with Hargreaves Lansdown now

The information included in this article does not constitute regulated financial advice. You should seek independent, professional financial advice before making any investment decision.

Comments


Do you want to comment on this article? You need to be signed in for this feature

Most Popular

Copyright © lovemoney.com All rights reserved.

 

loveMONEY.com Financial Services Limited is authorised and regulated by the Financial Conduct Authority (FCA) with Firm Reference Number (FRN): 479153.

loveMONEY.com is a company registered in England & Wales (Company Number: 7406028) with its registered address at First Floor Ridgeland House, 15 Carfax, Horsham, West Sussex, RH12 1DY, United Kingdom. loveMONEY.com Limited operates under the trading name of loveMONEY.com Financial Services Limited. We operate as a credit broker for consumer credit and do not lend directly. Our company maintains relationships with various affiliates and lenders, which we may promote within our editorial content in emails and on featured partner pages through affiliate links. Please note, that we may receive commission payments from some of the product and service providers featured on our website. In line with Consumer Duty regulations, we assess our partners to ensure they offer fair value, are transparent, and cater to the needs of all customers, including vulnerable groups. We continuously review our practices to ensure compliance with these standards. While we make every effort to ensure the accuracy and currency of our editorial content, users should independently verify information with their chosen product or service provider. This can be done by reviewing the product landing page information and the terms and conditions associated with the product. If you are uncertain whether a product is suitable, we strongly recommend seeking advice from a regulated independent financial advisor before applying for the products.